Israel Maxx Abramowitz - 14 Sep 2021 Form 3/A - Amendment Insider Report for Pasithea Therapeutics Corp. (KTTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3/A - Amendment
Accepted by SEC
07 Oct 2021, 16:09:19 UTC
Original report date
14 Sep 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Israel Maxx Abramowitz

Key filing fact

Israel Maxx Abramowitz filed Form 3/A - Amendment for Pasithea Therapeutics Corp. (KTTA) on 07 Oct 2021.

Key facts

  • This page summarizes Israel Maxx Abramowitz's Form 3/A - Amendment filing for Pasithea Therapeutics Corp. (KTTA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Oct 2021, 16:09.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KTTA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,051,575
Date
14 Sep 2021
Ownership
See Footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 3 was originally and incorrectly filed to disclose Israel Maxx Abramowitz as a 10% holder, specifically owning 1,051,575 shares of Common Stock through Epic Capital Inc. ("Epic"). At the time this Form 3 was originally filed, Mr. Abramowitz was the President and CEO of Epic and had sole voting and investment control with respect to the shares held by Epic. As such, Mr. Abramowitz may have be deemed to beneficially own the shares held directly by Epic. At this time, the 1,051,575 shares of Common Stock held by Epic represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Abramowitz is not a 10% holder.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .